ClinTec International has been operational in Western & Northern Europe since 1997, when the company was founded. Studies began shortly after covering Germany, France, the Netherlands, Italy and the UK. 

ClinTec has good relationships with key opinion leaders throughout the region, allowing us to provide invaluable knowledge and ensure that our studies are a complete success. With the benefit of an enlightened culture and positive attitudes towards participation in clinical trials, Western & Northern Europe is an ideal place for conducting studies.

Our global footprint in Western & Northern Europe extends to:

Austria / Belgium / Denmark / Estonia / Finland / France / Germany / Ireland / Italy / Latvia / Netherlands / Norway / Portugal / Spain / Sweden / Switzerland / UK
 

Why should you conduct studies in Western and Northern Europe?

Regulatory approval can be obtained within a maximum of 60 days, as all Western & Northern European countries are covered by the EU Clinical Trials Directive, which aims to streamline the clinical trial process in the EU. 

Movement of the study drug within the EU can be done without the need for multiple import licenses. 

Well-established, excellent healthcare systems e.g. Nordic countries have a healthcare database with all citizens records from birth 

Experienced investigators across a wide range of therapeutic areas